Compare XRTX & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XRTX | FRSX |
|---|---|---|
| Founded | 2011 | N/A |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4M | 4.7M |
| IPO Year | N/A | 2017 |
| Metric | XRTX | FRSX |
|---|---|---|
| Price | $0.57 | $1.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.8K | ★ 1.4M |
| Earning Date | 11-17-2025 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $452,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.51 | $0.90 |
| 52 Week High | $1.41 | $9.24 |
| Indicator | XRTX | FRSX |
|---|---|---|
| Relative Strength Index (RSI) | 45.75 | 20.80 |
| Support Level | $0.55 | $0.93 |
| Resistance Level | $0.60 | $1.46 |
| Average True Range (ATR) | 0.03 | 0.10 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 30.62 | 11.09 |
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.